Nicolás Peña

569 total citations
17 papers, 437 citations indexed

About

Nicolás Peña is a scholar working on Physiology, Neurology and Surgery. According to data from OpenAlex, Nicolás Peña has authored 17 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 4 papers in Neurology and 3 papers in Surgery. Recurrent topics in Nicolás Peña's work include Alzheimer's disease research and treatments (7 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Nicolás Peña is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Nicolás Peña collaborates with scholars based in Spain, Uruguay and United States. Nicolás Peña's co-authors include Francisco Muñoz, Inmaculada Alfageme, Carlos Fernández‐Viadero, Onofre Combarros, Javier Llorca, Jon Infante, José Berciano, Eloy Rodríguez‐Rodríguez, M. Sánchez–Guerra and Ignacio Mateo and has published in prestigious journals such as SHILAP Revista de lepidopterología, CHEST Journal and Journal of the Neurological Sciences.

In The Last Decade

Nicolás Peña

17 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicolás Peña Spain 12 150 129 102 60 53 17 437
Janet L. Rossi United States 8 219 1.5× 67 0.5× 163 1.6× 28 0.5× 69 1.3× 10 561
Billy Abungu United States 7 44 0.3× 83 0.6× 115 1.1× 58 1.0× 77 1.5× 9 386
Hongjie Li China 15 102 0.7× 74 0.6× 213 2.1× 22 0.4× 66 1.2× 39 589
Hongwei Cai China 12 61 0.4× 81 0.6× 243 2.4× 28 0.5× 79 1.5× 22 581
Iriana Colorado United States 9 44 0.3× 81 0.6× 100 1.0× 63 1.1× 81 1.5× 13 465
Chun‐Yu Niu China 10 49 0.3× 76 0.6× 78 0.8× 65 1.1× 41 0.8× 79 381
K S Gustafson United States 6 70 0.5× 55 0.4× 108 1.1× 17 0.3× 20 0.4× 6 487
Gal Levy United States 10 24 0.2× 51 0.4× 110 1.1× 40 0.7× 92 1.7× 24 355
Linjing Gong China 12 84 0.6× 96 0.7× 288 2.8× 16 0.3× 34 0.6× 27 562
Laura Servinsky United States 11 118 0.8× 122 0.9× 143 1.4× 10 0.2× 43 0.8× 17 385

Countries citing papers authored by Nicolás Peña

Since Specialization
Citations

This map shows the geographic impact of Nicolás Peña's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolás Peña with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolás Peña more than expected).

Fields of papers citing papers by Nicolás Peña

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolás Peña. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolás Peña. The network helps show where Nicolás Peña may publish in the future.

Co-authorship network of co-authors of Nicolás Peña

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolás Peña. A scholar is included among the top collaborators of Nicolás Peña based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolás Peña. Nicolás Peña is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Peña, Nicolás, et al.. (2021). Análisis biomecánico de la marcha en paciente con secuelas de poliomielitis y artroplastia de rodilla. SHILAP Revista de lepidopterología. 10(1). 75–88. 1 indexed citations
2.
Peña, Nicolás, et al.. (2019). Levofloxacin‐induced rhabdomyolysis in a patient on concurrent atorvastatin: Case report and literature review. Journal of Clinical Pharmacy and Therapeutics. 44(6). 966–969. 4 indexed citations
3.
Suárez, Hamlet, et al.. (2014). Unstable gait assessment with a portable analysis system. 181–185. 1 indexed citations
4.
Combarros, Onofre, C Leno, Agustı́n Oterino, et al.. (2009). Gender effect on apolipoprotein E 84 allele-associated risk for sporadic Alzheimer's disease. Acta Neurologica Scandinavica. 97(1). 68–71. 3 indexed citations
5.
Mateo, Ignacio, Pascual Sánchez‐Juan, Eloy Rodríguez‐Rodríguez, et al.. (2008). 14-3-3 Zeta and Tau Genes Interactively Decrease Alzheimer’s Disease Risk. Dementia and Geriatric Cognitive Disorders. 25(4). 317–320. 18 indexed citations
6.
Rodríguez‐Rodríguez, Eloy, Javier Llorca, Ignacio Mateo, et al.. (2007). No association of genetic variants of liver X receptor‐β with alzheimer's disease risk. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 147B(5). 650–653. 3 indexed citations
7.
Infante, Jon, Javier Llorca, Ignacio Mateo, et al.. (2007). Interaction between Poly(ADP-Ribose) Polymerase 1 and Interleukin 1A Genes Is Associated with Alzheimer’s Disease Risk. Dementia and Geriatric Cognitive Disorders. 23(4). 215–218. 33 indexed citations
8.
Riancho, José A., Carmen Valero, José L. Hernández, et al.. (2006). Association of the F352V variant of the Klotho gene with bone mineral density. Biogerontology. 8(2). 121–127. 35 indexed citations
9.
Combarros, Onofre, Jon Infante, Eloy Rodríguez‐Rodríguez, et al.. (2005). CD14 receptor polymorphism and Alzheimer's disease risk. Neuroscience Letters. 380(1-2). 193–196. 19 indexed citations
10.
Combarros, Onofre, Jon Infante, Javier Llorca, et al.. (2004). The chemokine receptor CCR5-Δ32 gene mutation is not protective against Alzheimer’s disease. Neuroscience Letters. 366(3). 312–314. 27 indexed citations
11.
Combarros, Onofre, Jon Infante, Javier Llorca, et al.. (2003). Age-Dependent Association between the Q7R Polymorphism in the Saitohin Gene and Sporadic Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders. 16(3). 132–135. 20 indexed citations
12.
Combarros, Onofre, Jon Infante, Javier Llorca, et al.. (2002). The myeloperoxidase gene in Alzheimer's disease: a case-control study and meta-analysis. Neuroscience Letters. 326(1). 33–36. 28 indexed citations
13.
Sánchez–Guerra, M., Onofre Combarros, Jon Infante, et al.. (2001). Case-control study and meta-analysis of low density lipoprotein receptor-related protein gene exon 3 polymorphism in Alzheimer's disease. Neuroscience Letters. 316(1). 17–20. 41 indexed citations
14.
Combarros, Onofre, et al.. (2000). The butyrylcholinesterase K variant is a protective factor for sporadic Alzheimer's disease in women. Acta Neurologica Scandinavica. 102(6). 350–353. 33 indexed citations
15.
Combarros, Onofre, Agustı́n Oterino, Miguel Delgado‐Rodríguez, et al.. (1999). Polymorphisms in the presenilin 1 and presenilin 2 genes and risk for sporadic Alzheimer’s disease. Journal of the Neurological Sciences. 171(2). 88–91. 11 indexed citations
16.
Berrazueta, José R., A Ochoteco, Maria Teresa Garcı́a-Unzueta, et al.. (1998). Age-Related Responses of Vasoactive Factors During Acute Exercise. Hormone and Metabolic Research. 30(11). 668–672. 17 indexed citations
17.
Alfageme, Inmaculada, et al.. (1993). Empyema of the Thorax in Adults. CHEST Journal. 103(3). 839–843. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026